Recombinant gp 350 Vaccine for Infectious Mononucleosis : A Phase 2 , Randomized , Double-Blind , Placebo-Controlled Trial to Evaluate the Safety , Immunogenicity , and Efficacy of an Epstein-Barr Virus Vaccine in Healthy Young Adults